Form D · Biotechnology

Kalgene Inc.

Montreal, A8 · CIK 0001867929

Offering snapshot reported Jan 20, 2022 · SEC filing

Reported sold
$4.76M
Offering amount: $4.76M
Investors reported
33
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 7, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.38M$4.76MJun 22, 2021: $2,686,581.00Jun 22, 2021Sep 28, 2021: $3,662,843.00Sep 28, 2021Jan 20, 2022: $4,762,843.00Jan 20, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,662,843 → $4,762,843
  • Reported investors29 → 33

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 20, 2022Amendment$4,762,843$1,100,000vs Sep 28, 202133SEC filing
Sep 28, 2021Amendment$3,662,843$976,262vs Jun 22, 202129SEC filing
Jun 22, 2021Initial$2,686,581No comparison16SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-403855

Source: Form D, filed Jan 20, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Eric Callaway Director, Executive
Benoit Cyr Director
Anthony J. Giovinazzo Director
Daniel Hetu Director
Jacki Jenuth Director, Executive
Nickolay V. Kukekov Executive
Michal Prywata Director
Thillainathan Yoganathan Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6100 Royalmount Avenue Nrc Building
Montreal, A8, H4P2R2